Revaprazan Hydrochloride CAS 178307-42-1 Assay ≥99.0% API Ụlọ ọrụ na-adị ọcha egosipụtara

Revaprazan Hydrochloride CAS 178307-42-1 Assay ≥99.0% API Ụlọ ọrụ dị ọcha

Nkọwa dị mkpirikpi:

Aha: Revaprazan Hydrochloride;Mgbanwe nke HCL

Ọnọdụ: 178307-42-1

Ọdịdị: White ma ọ bụ Gbanyụọ-White Crystalline Powder

Nyocha: ≥99.0%

Potassium-asọmpi acid blockers (P-CAB), na ọgwụgwọ nke duodenal ọnyá afọ, ọnya afọ na gastritis.

API Ogo dị elu, mmepụta azụmahịa

E-mail: alvin@ruifuchem.com

Zitere anyị email

Nkọwa ngwaahịa

Ngwaahịa ndị emetụtara

Mkpado ngwaahịa

Nkọwa:

Aha ọgwụ: Revaprazan Hydrochloride;Mgbanwe nke HCL
Ọnọdụ: 178307-42-1
API Ogo dị elu, mmepụta azụmahịa

Njirimara kemịkalụ:

Aha Chemical	Revaprazan Hydrochloride
Ụdị okwu	Mgbanwe nke HCL
Nọmba CAS	178307-42-1
Nọmba CAT	RF-API48
Ọnọdụ Ahịa	Na Akụrụngwa, Mpụta Ihe ruru narị narị kilograms
Usoro ihe omimi	C22H24ClFN4
Ibu molekụla	398.904
Ụdị	Ruifu Chemical

Nkọwapụta:

Ihe	Nkọwapụta
Ọdịdị	Ntụ ntụ kristal na-acha ọcha ma ọ bụ gbanyụọ
Solubility	Na-agbaze kpamkpam na chloroform, dichlormeth;Soluble na acetic acid;Na-edozi ntakịrị na methanol, DMSO;Ọ na-esiri ike na acetone, ACN;Ọ fọrọ nke nta ka ọ ghara ịsacha na ngwọta 0.1mol/L NaOH.0.1mol/L HCL ngwọta.
njirimara	Kwesịrị ịzaghachi nke ọma λ max 271nm, 205nm IR
Ebe Na-agbaze	219.0 ~ 222.0 ℃
Ịdị ọcha na Agba	Kwesịrị ịdị ọcha na enweghị agba na dichlormeth
Chloride	≤8.93%
Otu adịghị ọcha	≤0.10%
Mgbakọta adịghị ọcha	≤0.50%
Ọnwụ na ihicha	≤0.50%
Ihe fọdụrụ na mgbanye	≤0.10%
Sulfate	≤20ppm
Arsenic	≤10ppm
Ọla dị arọ	≤10ppm
Nyocha	≥99.0%
Nlele ọkọlọtọ	Standardkpụrụ ụlọ ọrụ
Ojiji	Ngwakọta ọgwụ na-arụ ọrụ (API)

Ngwungwu & Nchekwa:

ngwugwu: Kalama, Aluminom foil bag, kaadiboodu drum, 25kg / Drum, ma ọ bụ dị ka ndị ahịa chọrọ.

Ọnọdụ Nchekwa:Na-echekwa n'ime akpa ndị a kpuchiri ekpuchi na ebe dị jụụ na nke kpọrọ nkụ;Chebe site na ọkụ, mmiri mmiri na ụmụ ahụhụ.

Uru:

Ajụjụ:

Ngwa:

Shanghai Ruifu Chemical Co., Ltd. bụ onye na-emepụta ihe na onye na-ebubata Revaprazan Hydrochloride (CAS: 178307-42-1) nwere àgwà dị elu.Revaprazan Hydrochloride na-ebelata okwu COX-2 ma nwee nnukwu ihe omume mgbochi mkpali na ọrịa H. pylori.Revaprazan Hydrochloride na ọgwụgwọ nke ọnya duodenal, ọnya afọ na gastritis.
Revaprazan Hydrochloride (nke a makwaara dị ka reversible proton pump inhibitors, potassium competitive acid blockers, p-CABs) bụ ọgbọ ọhụrụ nke proton pump inhibitors na naanị ndị na-egbochi mgbapụta acid fatịlaịza potassium dị na ahịa ma ọ bụ ndị na-emegide mgbapụta acid na ụwa.Ụlọ ọrụ South Korea Yuhan mebere yana nwere ikike ọgụgụ isi, GLAxoSmithKline enwetala ikike mmepe na ịzụ ahịa zuru ụwa ọnụ maka ọgwụ na mpụga South Korea na North Korea.Ndị South Korea FDA kwadoro ọgwụ ahụ na 2007 iji gwọọ ọnya duodenal na gastritis.